Placenta
Volume 28, Issue 5 , Pages 543-556 , May 2007

The Role and Regulation of the Nuclear Factor Kappa B Signalling Pathway in Human Labour

  • M. Lappas

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 4th Floor, 163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Corresponding Author InformationCorresponding author: Tel.: +61 3 8458 4370; fax: +61 3 8458 4380.
    • ,
  • G.E. Rice

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 4th Floor, 163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Translational Proteomics, Baker Medical Research Institute, Baker Heart Research Institute, Melbourne, Victoria 3004, Australia

,Accepted 25 May 2006.

References 

  1. Haram K, Mortensen JHS, Wollen AL. Preterm delivery: an overview. Acta Obstet Gynecol Scand. 2003;82:687–704
  2. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Investig. 1999;6:285–292
  3. Fata JE, Ho ATV, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci. 2000;57:77–95
  4. Rice GE. Cytokines and the initiation of parturition. Front Horm Res. 2001;27:113–146
  5. Bowen JM, Chamley L, Keelan JA, Mitchell MD. Cytokines of the placenta and extra-placental membranes: Roles and regulation during human pregnancy and parturition. Placenta. 2002;23:257–273
  6. Lappas M, Rice GE. Phospholipase A2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids. 2004;70:87–100
  7. Emery JG, Ohlstein EH, Jaye M. Therapeutic modulation of transcriptional factor activity. Trends Pharmacol Sci. 2001;22:233–240
  8. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell. 2002;109:S81–S96
  9. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol. 2002;2:725–734
  10. Hayden MS, Ghosh S. Signaling to NF-kappa B.. Genes Dev. 2004;18:2195–2224
  11. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705–716
  12. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 1994;12:141–179
  13. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–681
  14. Bressler P, Brown K, Timmer W, Bours V, Siebenlist U, Fauci AS. Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant p50 mutants. J Virol. 1993;67:288–293
  15. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell. 1996;87:13–20
  16. Lernbecher T, Muller U, Wirth T. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature. 1993;365:767–770
  17. Carrasco D, Ryseck RP, Bravo R. Expression of RelB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development. 1993;118:1221–1231
  18. Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, et al. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol Cell Biol. 1992;12:674–684
  19. Zabel U, Henkel T, Silva MS, Baeuerle PA. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 1993;12:201–211
  20. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 1994;10:405–455
  21. Urban MB, Baeuerle PA. The role of the p50 and p65 of NF-κB in the recognition of cognate sequences. New Biol. 1991;3:279–288
  22. Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci U S A. 1992;89:1529–1533
  23. Cogswell PC, Scheinman RI, Baldwin AS. Promoter of the human NF-κB p50/p105 gene. Regulation of NF-κB subunits and by c-Rel. J Immunol. 1993;150:2794–2804
  24. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 1997;91:243–252
  25. Israel A. The IKK complex: an integrator of all signals that activate NF-κB?. Trends Cell Biol. 2000;10:129
  26. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to I kappa B kinases. Int Immunol. 1999;11:1357–1362
  27. O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem. 1998;273:30410–30414
  28. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of I kappa B kinase activity through IKK beta subunit phosphorylation. Science. 1999;284:309–313
  29. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 1995;9:1586–1597
  30. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell. 1995;80:529–532
  31. Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. The c-Rel proto-oncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type I human immunodeficiency virus. Proc Natl Acad Sci U S A. 1993;90:1023–1027
  32. Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene. 1999;18:6867–6874
  33. Beinke S, Ley SC. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem J. 2004;382:393–409
  34. Baeuerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111–137
  35. Lee J-I, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998;38:981–993
  36. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999;45:7–17
  37. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715–1722
  38. Morak R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. Activation of the transcription factor nuclear-factor kappa B in human inflamed synovial tissue. Arthritis Rheum. 1996;39:583–591
  39. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Baeuerle PA, et al. Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol. 1994;55:99–106
  40. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A. 1997;94:2642–2647
  41. Gveric D, Kaltschmidt C, Cuzner ML, Newcombe J. Transcription factor NF-κB and inhibitor IκBα are localised in macrophages in active multiple sclerosis lesions. J Neuropathol Exp Neurol. 1998;57:168–178
  42. Sha WC, Liou H-C, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 1995;80:321–330
  43. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 1995;80:331–340
  44. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, et al. Mice lacking the c-Rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995;9:1965–1977
  45. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, et al. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol Cell Biol. 1996;16:2341–2349
  46. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenic and knockouts. Oncogene. 1999;18:6888–6895
  47. King AE, Critchley HO, Kelly RW. The NF-κB pathway in human endometrium and first trimester decidua. Mol Hum Reprod. 2001;7:175–183
  48. Rosen T, Krikun G, Ma Y, Wang E-Y, Lockwood CJ, Guller S. Chronic antagonism of nuclear factor-κB activity in cytotrophoblasts by dexamethasone: a potential mechanism for anti-inflammatory action of glucocorticoids in human placenta. J Clin Endocrinol Metab. 1998;83:3647–3652
  49. Jung HS, Yoon BH, Jun JK, Kim M, Kim YA, Kim CJ. Differential activation of mitogen activated protein kinases and nuclear factor-κB in lipopolysaccharide-treated term and preterm amnion cells. Virchows Arch. 2005;447:45–52
  50. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor kappa B regulation of pro-inflammatory cytokines in human gestational tissues in vitro. Biol Reprod. 2002;67:668–673
  51. Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, pro-inflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab. 2003;88:1723–1729
  52. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of phospholipase isozymes by nuclear factor-κB in human gestational tissues in vitro. J Clin Endocrinol Metab. 2004;89:2365–2372
  53. Lappas M, Permezel M, Ho PW, Moseley JM, Wlodek ME, Rice GE. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. Placenta. 2004;25:669–704
  54. Kniss DA, Rovin B, Fertel RH, Zimmerman PD. Blockade NF-κB activation prohibits TNF-α induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells. Placenta. 2001;22:80–89
  55. Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PR. Nuclear factor-kappa B is essential for the up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod. 2001;7:787–790
  56. Yan XJ, Xiao CW, Sun MH, Tsang BK, Gibb W. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1β. Biol Reprod. 2002;66:1667–1671
  57. Allport VC, Slater DM, Newton R, Bennett PR. NF-κB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod. 2000;6:561–565
  58. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F. The nuclear transcription factor NF-κB mediates interleukin-1β-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol. 1999;181:359–366
  59. Chapman NR, Europe-Finner GN, Robson SC. Expression and deoxyribonucleic acid-binding activity of the nuclear factor kappa B family in the human myometrium during pregnancy and labor. J Clin Endocrinol Metab. 2004;89:5683–5693
  60. Yan X, Sun M, Gibb W. Localization of nuclear factor-κB (NF-κB) and inhibitory factor-κB (IκB) in human fetal membranes and decidua at term and preterm delivery. Placenta. 2002;23:288–293
  61. McCracken SA, Gallery E, Morris JM. Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success. J Immunol. 2004;172:4583–4591
  62. Dorr HG, Heller A, Versmold HT, Sippell WG, Herrmann M, Bidlingmaier RF, et al. Longitudinal-study of progestins, mineralocorticoids, and glucocorticoids throughout human-pregnancy. J Clin Endocrinol Metab. 1989;68:863–868
  63. Chapmam NR, Smyrnias I, Anumba OC, Europe-Finner N, Robson SC. Expression of the GTP-binding protein (Gαs) is repressed by the nuclear factor kB RelA subunit in human myometrium. Endocrinology. 2005;146:4994–5005
  64. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappa B activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod. 2001;7:581–586
  65. Condon JC, Hardy DB, Kovaric K, Mendelson CR. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear Factor-kappa B may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol. 2006;20:764–775
  66. Baggia S, Gravett MG, Witkin SS, Haluska GJ, Novy MJ. Interleukin-1 beta intra-amniotic infusion induces tumor necrosis factor-alpha, prostaglandin production, and preterm contractions in pregnant rhesus monkeys. J Soc Gynecol Invest. 1996;3:121–126
  67. Cox SM, King MR, Casey ML, MadDonald PC. Interleukin-1β, interleukin-1α and interleukin-6 and prostaglandins in vaginal cervical fluids of pregnant-women before and during labor. J Clin Endocrinol Metab. 1993;77:805–815
  68. Laham N, Brennecke SP, Bendtzen K, Rice GE. Differential release of interleukin-6 from human gestational tissues in association with labour and in vitro endotoxin treatment. J Endocrinol. 1996;49:431–439
  69. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol. 1992;27:117–123
  70. Dudley DJ, Chen C-L, Branch DW, Hammond E, Mitchell MD. A murine model of preterm labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua. Biol Reprod. 1993;48:33–39
  71. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol. 1989;143:1366
  72. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NF-κB, and Sp1 transcription factors. J Biol Chem. 1995;270:27920–27931
  73. Goldfeld AE, Doyle C, Maniatis T. Human tumor necrosis factor gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci U S A. 1990;87:9769–9773
  74. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, et al. Novel inhibitors of cytokine-induced IκB-α phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997;272:21096–21103
  75. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of pro-inflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via NF-κB, PPAR-γ and ERK 1/2. Endocrinology. 2005;146:3334–3342
  76. Soloff MS, Cook DL, Jeng YJ, Anderson GD. In situ analysis of interleukin-1-induced transcription of cox-2 and il-8 in cultured human myometrial cells. Endocrinology. 2004;145:1248–1254
  77. Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin-1β and interleukin-6 by fragments of term placental villi: signalling pathways and effects of tumour necrosis factor α and mode of deliver. Placenta. 2002;23:467–474
  78. Strewler GJ. The parathyroid hormone-related protein. Endocrinol Metab Clin North Am. 2000;29:629–645
  79. Wlodek ME, Koutsis K, Westcott KT, Ho PWM, Di Nicolantonio R, Moseley JM. The spontaneously hypertensive rat fetus, not the mother, is responsible for the reduced amniotic fluid PTHrP concentrations and growth restriction. Placenta. 2001;22:646–651
  80. Ferguson JE, Seaner RM, Bruns DE, Iezzoni JC, Bruns E. Expression and specific immunolocalisation of the human parathyroid hormone/parathyroid hormone-related protein receptor in the uteroplacental unit. Am J Obstet Gynecol. 1998;179:321–329
  81. Wlodek ME, Ho PW, Rice GE, Moseley JM, Martin TJ, Brennecke SP. Parathyroid hormone-related protein (PTHrP) concentrations in human amniotic fluid during gestation and at the time of labour. Reprod Fertil Dev. 1995;7:1509–1513
  82. Curtis NE, Ho PW, King RG, Farrugia W, Moses EK, Gillespie MT, et al. The expression of parathyroid hormone-related protein mRNA and immunoreactive protein in human amnion and choriodecidua is increased at term compared with preterm gestation. J Endocrinol. 1997;154:103–112
  83. Farrugia W, Ho PW, Rice GE, Moseley JM, Permezel M, Wlodek ME. Parathyroid hormone-related protein(1–34) in gestational fluids and release from human gestational tissues. J Endocrinol. 2000;165:657–662
  84. Ichizuka K, Morimoto T, Suzuki M, Sasaki Y, Kurihara H, Saito H, et al. The effect of cytokines on parathyroid hormone-related protein (PTHrP) production in human amnion cells. Endocr J. 1999;46:479–486
  85. Keirse MJNC. Eicosanoids in human pregnancy and parturition. In: Eicosanoids in reproduction. Mitchell MD, editor.. Boca Raton: CRC Press; 1990;
  86. Helliwell RJA, Adams LF, Mitchell MD. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids. 2004;70:101–113
  87. Romero R, Emamian M, Wan M, Quintero R, Hobbins JC, Mitchell MD. Prostaglandin concentrations in amniotic fluid of women with intraamniotic infection and preterm labour. Am J Obstet Gynecol. 1987;157:1461–1467
  88. Romero R, Wu YK, Hobbins JC, Mitchell MD. Amniotic fluid prostaglandin E2 in preterm labour. Prostaglandins Leukot Essent Fatty Acids. 1988;34:141–145
  89. Embrey MP. Induction of abortion by prostaglandin E1 and E2. Br Med J. 1970;2:258–260
  90. Karim SM. Therapeutic abortion using prostaglandin F2α. Lancet. 1970;1:157–159
  91. Harper MJ, Skarnes RC. Inhibition of abortion and fetal death produced by endotoxin or prostaglandin F2α. Prostaglandins. 1972;2:295
  92. Freed KA, Moses EK, Brennecke SP, Rice GE. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term. Mol Hum Reprod. 1997;3:493–499
  93. Rice GE. Secretory phospholipases and membrane polishing. Placenta. 1998;19:13–20
  94. Rice GE, Brennecke SP, Scott KF, Smith GM, Rajkovic IA, Bishop GJ. Elevated maternal plasma immunoreactive phospholipase A2 in human preterm and term labour. Eicosanoids. 1992;5:9–12
  95. Koyama M, Ito S, Nakajima A, Shimoya K, Azuma C, Suehara N, et al. Elevations of group II phospholipase A2 concentrations in serum and amniotic fluid in association with preterm labour. Am J Obstet Gynecol. 2000;183:1537–1543
  96. Nguyen HT, Rice GE, Farrugia W, Wong M, Brennecke SP. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua. Biol Reprod. 1994;50:526–534
  97. Farrugia W, Rice GE, Wong MH, Scott KF, Brennecke SP. Release of type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta. J Endocrinol. 1997;153:151–157
  98. Xue S, Brockman DE, Slater DM, Myatt L. Interleukin-1 beta induces the synthesis and activity of cytosolic phospholipase A2 and the release of prostaglandin E2 in human amnion-derived WISH cells. Prostaglandins. 1995;49:351–369
  99. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991;266:2647–2651
  100. Couturier C, Brouillet A, Couriaud C, Koumanov K, Bereziat G, Andreani M. Interleukin-1β induces type II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process. J Biol Chem. 1999;274:23085–23093
  101. Tay A, Maxwell P, Li Z, Goldberg H, Skorecki K. Isolation of promoter for cytosolic phospholipase A2 (cPLA2). Biochim Biophys Acta. 1994;1217:345–347
  102. Miyashita A, Crystal RG, Hay JG. Identification of a 27 bp 5′-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene. Nucleic Acids Res. 1995;23:293–301
  103. Wang Z, Tai HH. Interleukin-1β and dexamethasone regulate gene expression of prostaglandin H synthase-2 via the NF-κB pathway in human amnion derived WISH cells. Prostaglandins Leukot Essent Fatty Acids. 1998;59:63–69
  104. Lappas M, Yee K, Permezel M, Rice GE. Lipopolysaccharide and TNF-α activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta. 2006;27:568–575
  105. Ackerman VE, Rovin BH, Kniss DA. Epidermal growth factor and interleukin-1β utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol Reprod. 2004;71:2079–2086
  106. Hansen WR, Marvin KW, Potter S, Mitchell MD. TNF-α regulation of PGHS-2 transcription is not through NF-κB in amnion-derived AV3 cells. Placenta. 2000;21:789–798
  107. Potter S, Mitchell MD, Hansen WR, Marvin KW. NF-IL6 and CRE elements principally account for both basal and interleukin-1β induced transcriptional activity of the proximal 528 bp of the PGHS-2 promoter in amnion-derived AV3 cells: evidence for the involvement of C/EBPb. Mol Hum Reprod. 2000;6:771–778
  108. Rath W, Winkler M, Kemp B. The importance of extracellular matrix in the induction of preterm delivery. J Perinat Med. 1998;26:437–441
  109. Winkler M, Fischer DC, Ruck P, Marx T, Kaiserling E, Oberpichler A, et al. Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. Hum Reprod. 1999;14:1096–1100
  110. Tsatas D, Baker MS, Moses EK, Rice GE. Gene expression of plasminogen activation cascade components in human term gestational tissues with labour onset. Mol Hum Reprod. 1998;4:101–106
  111. Tsatas D, Baker MS, Rice GE. Differential expression of proteases in human gestational tissues before, during and after spontaneous-onset labour at term. J Reprod Fertil. 1999;116:43–49
  112. Roh C-R, Oh W-J, Yoon B-K, Lee J-H. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod. 2000;6:96–102
  113. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss JF. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol. 1996;174:1371–1376
  114. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med. 1999;27:362–368
  115. Vadillo-Ortega F, Estrada-Gutiérrez G. Role of matrix metalloproteinases in preterm labour. Br J Obstet Gynaecol. 2005;112:19–22
  116. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene 92-kDa type IV collagenase. J Biol Chem. 1991;266:16485–16490
  117. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci. 1999;56:104–132
  118. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin-10 inhibits nuclear factor κB activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995;270:9558–9563
  119. Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus complicated pregnancies. J Endocrinol. 2005;186:457–465
  120. Dreyer MG, Juge-Aubry CE, Gabay C, Lang U, Rohner-Jeanrenaud F, Dayer JM, et al. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor κB/PUC1 binding site. Biochem J. 2003;370:591–5999
  121. Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev. 2001;21:185–210
  122. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82–86
  123. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 1998;391:79–82
  124. Park EJ, Park SY, Joe EH, Jou I. 15d-PGJ2 and rosilglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J Biol Chem. 2003;278:14747–14752
  125. Giri S, Rattan R, Singh AK, Singh I. The 15-deoxy-Δ12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol. 2004;173:5196–5208
  126. Scher JU, Pillinger MH. 15d-PGJ2: the anti-inflammatory prostaglandin?. Clin Immunol. 2005;114:100–109
  127. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of pro-inflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Δ12,14-PGJ2 and troglitazone. J Clin Endocrinol Metab. 2002;87:4667–4672
  128. Lappas M, Permezel M, Rice GE. 15-Deoxy-Δ12,14-prostaglandin J2 and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta, in press.
  129. Berry EA, Keelan JA, Helliwell RJA, Gilmour RS, Mitchell MD. Nanomolar and micromolar effects of 15-deoxy-Δ12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferators-activated receptors γ and δ and nuclear factor κB. Mol Pharmacol. 2005;68:169–178
  130. Ackerman WE, Zhang XL, Rovin BH, Kniss DA. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARγ ligands through NF-κB signal disruption in human WISH and amnion cells. Biol Reprod. 2005;73:527–535
  131. Lindström TM, Bennett PR. 15-Deoxy-12,14-prostaglandin J2 inhibits interleukin-1β-induced nuclear factor-κB in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab. 2005;90:3534–3543
  132. Milne GL, Musiek ES, Morrow JD. The cyclopentenone (A2/J2) isoprostanes – unique, highly reactive products of arachidonate peroxidation. Antioxid Redox Signal. 2005;7:210–220
  133. Musiek ES, Milne GL, Han W, Brett Everhart M, Wang D, Backlund MG, et al. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem. 2005;280:35562–35570
  134. Leslie KK, Lee SL, Woodcock SM, Davies JK, McDuffie RS, Hirsch E, et al. Acute intrauterine infection results in an imbalance between pro- and anti-inflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol. 2000;43:305–311
  135. Kramer BW, Kaemmerer U, Kapp M, Herbst D, Marx A, Berg D, et al. Decreased expression of angionenic factors in placentas with chorioamnionitis after preterm birth. Pediatr Res. 2005;58:607–612
  136. Condon JC, Jeyasuria F, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A. 2004;101:4978–4983
  137. Sadowsky DW, Novy MJ, Witkin SS, Gravett MG. Dexamethasone or interleukin-10 blocks interleukin-1 beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol. 2003;188:252–263

PII: S0143-4004(06)00156-1

doi: 10.1016/j.placenta.2006.05.011

Placenta
Volume 28, Issue 5 , Pages 543-556 , May 2007

Article Tools

* Image Usage & Resolution